Related by context. All words. (Click for frequent words.) 70 oral prodrug 70 torezolid 70 vidofludimus 70 Hsp# Inhibitor 69 Omacetaxine 69 Pharmacokinetic studies 69 Darinaparsin 69 selective modulator 69 generation purine nucleoside 69 Panzem R NCD 69 PDE4 inhibitor 69 AAG geldanamycin analog 68 demonstrated antitumor activity 68 liposomal formulation 68 uricase 68 Blinatumomab 68 pharmacodynamic properties 68 PEG SN# 68 OMP #M# 68 receptor tyrosine kinase inhibitor 68 nucleoside analog 68 Archexin 68 topically administered 68 Onconase 68 oral methylnaltrexone 68 HuLuc# 68 administered subcutaneously 68 JAK2 inhibitor 68 favorable pharmacokinetic profile 68 Initiates Clinical 68 intranasal formulation 68 vascular disrupting agent 68 novel VDA molecule 68 Traficet EN 68 oral salmon calcitonin 68 HCV protease inhibitors 68 Safinamide 68 relapsed MM 68 humanized monoclonal 68 riociguat 68 ritonavir boosted 67 fosbretabulin 67 Interferon alpha 67 orally administered inhibitor 67 preclinically 67 SCH # 67 orally inhaled migraine 67 cMET 67 volociximab 67 proteasome inhibitor 67 mertansine 67 PD LID 67 Spiegelmer ® 67 Lubiprostone 67 potent antiproliferative 67 CCR5 antagonist 67 Symadex 67 metaglidasen 67 ENMD # 67 NXL# 67 Dasatinib 67 Granulocyte Colony Stimulating Factor 67 Dapagliflozin 67 JAK inhibitor 67 cannabinor 67 Multimeric 67 CYT# potent vascular disrupting 67 pathophysiological effects 67 subcutaneously administered 67 2A receptor agonist 67 Oxytrex TM 67 injectable investigational 67 evaluating tivozanib 67 p# inhibitor 67 JAK Inhibitor 67 humanised monoclonal antibody 67 Phase 1a clinical 67 SUTENT ® 66 YONDELIS 66 HuMax EGFr 66 PEGylated interferon 66 preclinical efficacy 66 Carfilzomib 66 Orally administered 66 vinca alkaloid 66 bortezomib Velcade 66 Pazopanib 66 nucleotide analog 66 pan HDAC inhibitor 66 PNP inhibitor 66 Annamycin 66 investigational humanized monoclonal antibody 66 afamelanotide 66 TO AVOID PREGNANCY WHILE 66 Presents Preclinical Data 66 Zalypsis 66 PRT# 66 TBC# 66 histone deacetylase inhibitor 66 CA9 SCAN 66 reversible inhibitor 66 Factor VIIa 66 targeted antifolate 66 #ME# 66 pharmacodynamic profile 66 AKT inhibitor 66 Tarceva TM 66 trodusquemine 66 Nilotinib 66 Anticalins R 66 Kinoid 66 LT NS# 66 beta 1a 66 targeted radiotherapeutic 66 Aurora Kinase 66 Pegylated 66 pegylated 66 LB# [003] 66 peripherally acting 66 aripiprazole Abilify 66 Preclinical studies suggest 66 PEGylated anti 66 DermaVir 66 alefacept 66 pharmacodynamic markers 66 GMX# 66 Meets Primary Endpoint 66 Anidulafungin 66 Solulin 66 BAL# [002] 66 DermaVir Patch 66 RhuDex ® 66 Maribavir 66 CBLC# 66 Initiates Phase II 66 tezampanel NGX# 66 anti amnesic 66 Phase #b/#a 66 synthetic siRNA 66 vivo validation 66 Xanafide 66 delafloxacin 66 orally dosed 66 novel oral anticoagulant 66 Anavex #-# 66 PSN# [002] 66 long acting muscarinic 66 MAGE A3 ASCI 66 CTAP# Capsules 66 R roscovitine 66 therapeutic monoclonal antibody 65 XmAb# 65 PSN# [001] 65 Vaxfectin TM 65 Silodosin 65 Panzem NCD 65 itraconazole Sporanox 65 highly selective endothelin 65 tigecycline 65 RH1 65 mGluR2 NAM 65 small molecule chemotherapeutic 65 Pertuzumab 65 oral picoplatin 65 HDACi 65 Dual Opioid 65 erythropoietic 65 Akt inhibitor 65 Pimavanserin 65 TNF Tumor Necrosis Factor 65 cathepsin K inhibitor 65 Golimumab 65 Interferon Beta 65 PEGylated 65 macrolide antibiotics 65 Initiates Enrollment 65 ulimorelin 65 receptor inhibitor 65 GLPG# 65 USL# 65 multitargeted 65 sorafenib tablets 65 Phase Ib clinical 65 oral rivaroxaban 65 Squalamine 65 Elesclomol 65 Preclinical Data 65 Personalized Immunotherapy 65 Pathway Inhibitor 65 Sym# 65 immunomodulating 65 NS#/#A protease 65 PSMA ADC 65 RAV# 65 Multiple Ascending Dose 65 selective inhibition 65 pharmacodynamic PD 65 Romidepsin 65 visilizumab 65 immunomodulatory 65 oral renin inhibitor 65 selective antagonist 65 Laquinimod 65 Alfacell proprietary ribonuclease 65 novel peptide 65 Enhanze Technology 65 Lixivaptan 65 Phase Ib study 65 hypoxia activated prodrug 65 Alzhemed TM 65 Dalbavancin 65 SPRYCEL ® 65 Omacetaxine mepesuccinate 65 forodesine 65 Presents Preclinical 65 S/GSK# 65 taxane derivative 65 SYN# 65 HGS# 65 anticancer activity 65 atacicept 65 CTA# 65 antiproliferative effects 65 TRX1 65 serotonin norepinephrine reuptake inhibitor 65 Bendamustine 65 Cardiotoxicity 65 Tamibarotene 65 CIMZIA TM 65 ganetespib 65 Darusentan 65 HQK 65 Fc fusion protein 65 muscarinic 65 NOX E# 65 Aliskiren 65 LAB CGRP 65 SinuNase ™ 65 Tolvaptan 65 TG# [003] 65 HGS ETR2 65 CEQ# 65 acyclovir Lauriad R 65 vascular disrupting agents 65 IAP inhibitor 65 antidiabetic 65 selective agonist 65 sargramostim 65 antiviral efficacy 64 Lu AA# 64 phase IIa clinical 64 Irinotecan 64 oral antiviral 64 ceftazidime 64 anti secretory 64 HSP# inhibitor 64 antibody MAb 64 Oral NKTR 64 somatostatin analog 64 ibudilast 64 JAK2 Inhibitor 64 thorough QT 64 cytoprotective 64 MGd 64 ESBA# 64 PrevOnco ™ 64 hyperphenylalaninemia HPA due 64 MEK inhibitors 64 topical ophthalmic 64 Zemplar Capsules 64 tumor vascular disrupting 64 Angiotensin Converting Enzyme 64 Cethromycin 64 antiangiogenic agent 64 Bicifadine 64 Anticalins 64 Methylnaltrexone 64 ATL# [002] 64 next generation URAT1 64 thalidomide Thalomid 64 TNF alpha inhibitor 64 immune modulating 64 orally inhaled 64 MTP inhibitor 64 IMiDs ® 64 TELINTRA 64 non nucleoside inhibitor 64 Bosutinib 64 HCl capsules 64 Trofex 64 LPA1 receptor 64 Alvesco R 64 mTOR inhibitors 64 SAR# [004] 64 Trandolapril 64 5 HT2A receptor 64 intradermal injection 64 INCB# [001] 64 TRO# 64 Cannabinor 64 AEGR 64 Vernakalant 64 KRN# 64 TOCOSOL Camptothecin 64 chimeric monoclonal antibody 64 PEGPH# 64 cilengitide 64 Antitumor 64 KSP inhibitor 64 Tasimelteon 64 Phase #b/#a trial 64 small molecule tyrosine 64 virus HCV protease inhibitor 64 cediranib 64 zoledronate 64 CB2 selective receptor agonist 64 Bruton tyrosine kinase Btk 64 subcutaneous SC 64 Vidaza azacitidine 64 OMNARIS HFA 64 Cloretazine 64 imatinib Gleevec ® 64 prescribed proton pump 64 lenalidomide dexamethasone 64 milatuzumab 64 Temsirolimus 64 phase IIb trial 64 MEK inhibitor 64 histamine dihydrochloride 64 ALB # 64 small molecule thrombopoietin 64 intravenous dosing 64 sunitinib malate 64 phase IIb III 64 5 HT2A 64 Tezampanel 64 Fingolimod 64 investigational monoclonal antibody 64 novel emulsion formulation 64 erlotinib Tarceva ® 64 TÎ ² 4 64 SNT MC# 64 antitumoral 64 ocular formulation 64 acetonide FA 64 Mipomersen 64 Iloperidone 64 VAPRISOL 64 subcutaneous formulation 64 VEGF inhibitors 64 AQ4N 64 Phase Ib II 64 DXL# 64 Bucindolol 64 pregabalin Lyrica 64 antitumor effect 64 albiglutide 64 Aflibercept 64 inhaled formulations 64 adenosine A2A 64 refractory chronic lymphocytic 64 antiapoptotic 64 phase Ib 64 pharmacodynamic effects 64 antitumor 64 Genz # 64 Phase 1b trial 64 Elagolix 64 CCR9 antagonist 64 Elvitegravir 64 Solorel TM 64 pharmacokinetic interactions 64 VA# [002] 64 JAK inhibitors 64 peptide conjugated 64 Interferon beta 1a 64 intranasal delivery 64 Panzem R 64 estramustine 64 Androxal TM 64 solithromycin 64 Voreloxin 64 monoclonal anti 64 antiplatelet agent 64 Tyrima 64 hematological parameters 64 TransVax ™ 64 ara C 64 gemcitabine Gemzar ® 64 Muraglitazar 64 oral beclomethasone dipropionate 64 Universal Flu Vaccine 64 teriflunomide 64 corticosteroid dexamethasone 64 nasal spray formulation 64 Kamada AAT 64 Aplidin 64 Zybrestat 64 Pharmacokinetics PK 64 immunomodulatory properties 64 SPC# [001] 64 etanercept Enbrel 64 mGluR5 NAM 64 GHRH 64 Vidofludimus 64 IMiDs R 64 Begins Dosing 64 protein tyrosine phosphatase 1B 64 GV# [001] 64 2 methoxyestradiol 64 elotuzumab 64 Valdoxan 64 indibulin 64 Melphalan 64 orally bioavailable 64 torezolid phosphate 63 RLY# 63 Chemophase 63 cytokine refractory 63 Degarelix 63 Febuxostat 63 TransVax tm 63 mediated inhibition 63 Initiate Phase 63 Anticalin R 63 selectively inhibits 63 Anticalins ® 63 THR beta agonist 63 Alferon N 63 ALGRX 63 sorafenib Nexavar 63 OvaRex R 63 radezolid 63 non porcine pancreatic 63 Cimzia TM 63 Apoptone 63 DU #b 63 BCR ABL inhibitors 63 inhaled iloprost 63 YONDELIS R 63 AEG# 63 pharmacodynamic endpoints 63 Sitagliptin 63 highly selective inhibitor 63 clevidipine 63 cidofovir 63 TLR9 agonist 63 plasma pharmacokinetics 63 hMG 63 Phase III Clinical Trial 63 Forodesine HCl 63 Dyloject TM 63 immunomodulator 63 Sapacitabine 63 Cethrin R 63 histone deacetylase HDAC inhibitor 63 ciprofloxacin hydrochloride 63 intravenously administered 63 alvespimycin 63 guanfacine extended release 63 TLR8 agonist 63 nalbuphine ER 63 immune modulatory 63 Ofatumumab 63 MNTX 63 FOLFOX6 chemotherapy regimen 63 Curaxin 63 lumiliximab 63 retaspimycin 63 cobiprostone 63 Factor Xa inhibitor 63 phase IIb clinical 63 small molecule activators 63 Nanobody ® 63 PREOS R 63 phase IIa 63 fluoroquinolone antibiotic 63 CCX# 63 mitogen activated ERK kinase 63 busulfan 63 adalimumab Humira 63 HDL Mimetic Peptide 63 reuptake inhibitor 63 CIMZIA R 63 aurora kinase 63 Thiovir 63 Phase IIb Trial 63 5 HT4 receptor 63 vapreotide acetate 63 CYT# QbG# 63 FTY# fingolimod 63 BCR ABL inhibitor 63 maximally tolerated dose 63 targeting CD# 63 anticancer compound 63 antisense inhibitors 63 midstage clinical 63 nitazoxanide 63 vivo potency 63 Zysolin TM 63 Anti VEGF 63 Panzem 63 recombinant interferon 63 intermittent dosing 63 brivaracetam 63 CYP#A# CYP#D# 63 thetreatment 63 partial agonist 63 alagebrium 63 miconazole Lauriad ® 63 topical gel formulation 63 nanoviricides 63 selective orally bioavailable 63 antagonist LAMA 63 XOMA 3AB 63 Evoltra ® 63 Antitumor Activity 63 Bevasiranib 63 herpetic keratitis 63 Gleevec resistant 63 basal insulin analogue 63 radiation sensitizer 63 immunomodulatory effects 63 Clinical Trial Results 63 IMiDs ® compound 63 Rotigotine 63 rhITF 63 meropenem 63 Completes Patient Enrollment 63 neuroprotective properties 63 Investigational Compound 63 CA4P 63 prodrugs 63 APOPTONE 63 macrolide antibiotic 63 Lisofylline LSF 63 somatostatin analogue 63 Ambrisentan 63 Quinamed 63 NP2 Enkephalin 63 PORxin TM 63 Ciclesonide 63 Glatiramer Acetate 63 inecalcitol 63 toenail onychomycosis 63 systemically administered 63 INT# [002] 63 Tß4 63 lomitapide 63 Elotuzumab 63 XP# XP# 63 Octreolin 63 salmeterol fluticasone 63 FluCide 63 Deforolimus 63 CCR5 inhibitor 63 receptor antagonism 63 TPI ASM8 63 PEGylated Fab fragment 63 somatostatin 63 depsipeptide 63 antiangiogenic 63 aplindore 63 gamma secretase inhibitor 63 mTOR inhibition 63 HCV polymerase 63 parenterally administered 63 calcitonin gene related 63 potent suppressor 63 peptibody 63 class mGluR5 inhibitor 63 cardioprotective effects 63 pharmacokinetic PK study 63 anti leukemic 63 Carvedilol 63 Pitavastatin 63 cisplatin gemcitabine 63 Poly ICLC 63 selective androgen receptor modulator 63 GLP toxicology studies 63 velafermin 63 Tyrosine Kinase Inhibitor 63 Myolimus 63 non nucleoside 63 semi synthetic lipoglycopeptide 63 potent anticancer 63 ARIKACE ™ 63 plasma kallikrein inhibitor 63 Vaxfectin 63 PI3K inhibitor 63 MLN# 63 angiogenesis inhibitor 63 anti CD3 63 viral kinetics 63 amprenavir 63 pomalidomide 63 Tesetaxel 63 Aptivus ® 63 antitumor efficacy 63 microtubule inhibitor 63 Lacosamide 63 SR# [004] 63 M# rationally 63 Albuferon TM 63 GLP1 agonist 63 intravesical 63 accumulate preferentially 63 interferon gamma 1b 63 selective kinase inhibitor 63 DAVANAT 63 GLYX 63 mesalazine 63 huC# DM4 63 biologic DMARD 63 Annexin V 63 combinability 63 Lamotrigine 63 canakinumab 63 PEP# [003] 63 topoisomerase II inhibitor 63 leukotriene receptor antagonists 63 synthetic retinoid 63 antimitotic 63 platelet inhibitor 63 xanthine oxidase inhibitor 63 sodium glucose cotransporter 63 rabeprazole 63 EP #R 63 DNA intercalator 63 antiresorptive 63 NEUGENE antisense 63 docetaxel Taxotere ® 63 octreotide acetate 63 Teriflunomide 63 Bezielle 63 GW# [003] 63 urate oxidase 63 uric acid lowering 63 kinase inhibition 63 multicenter Phase II 63 concurrent chemoradiation 63 novel immunomodulatory 63 #I TM# 63 epigenetic therapies 63 H#N# VLP vaccine 63 PROSTVAC VF 63 Vilazodone 63 Phase 2a Clinical Trial 63 orally disintegrating 63 tubulin inhibitor 63 urate lowering 63 ZOLINZA 63 CCX# B 63 pharmacokinetic parameters 63 Pivotal Phase III 63 selective A2A adenosine receptor 63 CDK inhibitor 63 immunomodulatory therapy 62 5 FU leucovorin 62 acyclovir Lauriad ® 62 anti fibrotic 62 mapatumumab 62 kidney urologic 62 Immunotherapeutic 62 nucleoside reverse transcriptase inhibitor 62 antifibrotic 62 Triapine R 62 inhibit platelet function 62 Sanvar R 62 miconazole 62 investigational oral 62 tezampanel 62 CYP #A# 62 candidate TNFerade biologic 62 inhibitor PPI 62 daily subcutaneous injections 62 Naproxcinod 62 tolerability pharmacokinetics 62 BNC# 62 antiangiogenic agents 62 REP# 62 bendamustine 62 prokinetic agent 62 BRAF inhibitors 62 Transdermal Patch 62 dihydrofolate reductase 62 IAP inhibitors 62 Guanilib 62 delta isoform 62 Phase 2b Clinical Trial 62 bosutinib 62 oxidative stress inducer 62 Cancidas 62 Anticalin ® 62 PGL# 62 Epothilones 62 acadesine 62 Plicera 62 fusion enhancers 62 Xcytrin R 62 rhIGF-I/rhIGFBP-3 62 inverse agonist 62 potent cytotoxic 62 Drug Candidate 62 Cleviprex TM clevidipine 62 rxRNA 62 FOLOTYN ® 62 Mycophenolate Mofetil 62 ruxolitinib 62 Phase IIIb clinical 62 DOS# 62 Epanova 62 TRV# [001] 62 Neulasta ® 62 Angiocept 62 ONCONASE R 62 RhuDex R 62 BN# [004] 62 abacavir Ziagen 62 echinocandins 62 leukotriene receptor antagonist 62 Belerofon 62 dihydrochloride 62 Relivar 62 ospemifene 62 metastatic neuroendocrine tumors 62 HDAC Inhibitor 62 pharmacokinetic PK profile 62 Telithromycin 62 Mg Usa 62 Rigel R# 62 xenograft models 62 safety tolerability pharmacokinetic 62 dimebon latrepirdine 62 rhFVIIa 62 pharmacokinetic characteristics 62 Reports Preclinical Data 62 TKM ApoB 62 neratinib 62 Initiate Clinical Trial 62 preclinical pharmacokinetic 62 nab paclitaxel 62 #mg/#mg 62 ISTODAX 62 ASONEP 62 Ropinirole 62 Aeroquin 62 Lodotra TM 62 insulin sensitizers 62 topical antifungal 62 TNF alpha selectively neutralizing 62 Ecallantide 62 Tacrolimus 62 5 HT3 receptor 62 CD# CEA 62 HepDirect prodrug 62 Enzastaurin 62 bronchodilatory 62 non nucleoside HCV 62 pharmacokinetic pharmacodynamic 62 SGLT 2 62 ALN TTR# 62 desvenlafaxine succinate 62 PPAR gamma agonist 62 optimal dosing regimens 62 CDP# 62 KB# [002] 62 fumarate 62 AZILECT R 62 Erlotinib 62 QVA# 62 Inhalation Solution 62 favorable pharmacokinetic 62 TH# [003] 62 neuroprotectant 62 glucagon receptor 62 radiotherapeutic 62 TLK# 62 Antiangiogenic 62 leukotriene B4 62 FUSILEV enhances 62 antiproliferative 62 anti CD3 antibody 62 Bendavia 62 griseofulvin 62 Vascugel 62 tarenflurbil 62 humanized anti 62 2 inhibitor CYT# 62 OXi# 62 factor Xa inhibitor 62 Protelos 62 Azedra TM 62 H2 antagonists 62 NB S# strontium malonate 62 dosing frequency 62 GAP #B# 62 Iluvien ® 62 daptomycin 62 methylnaltrexone bromide 62 atrasentan 62 HGS ETR1 62 PREOS 62 AZILECT ® 62 Adenoscan R 62 Kinase Inhibitor 62 ACAPODENE TM 62 budesonide foam 62 NEUGENE 62 TAFA# 62 signal transduction inhibitor 62 PEGylated interferon beta 1a 62 alkylating agent 62 effector function 62 beta interferons 62 potent antitumor 62 5alpha reductase 62 HCV RNA polymerase 62 MP4OX 62 teduglutide 62 delta opioid receptor 62 lipopeptide 62 posaconazole 62 Ceflatonin 62 Phase 1b clinical 62 Noxafil 62 ALK inhibitors 62 Cloretazine ® 62 Sphingomab 62 investigational protease inhibitor 62 novel histone deacetylase 62 Initiates Clinical Trial 62 anti anginal 62 aspirin clopidogrel 62 PET tracers 62 p# MAP kinase inhibitor 62 triphendiol 62 beta lactam antibiotic 62 OXIGON TM 62 Peginterferon alfa 2b 62 ixabepilone 62 GVAX ® 62 Phase IIB 62 PEG IFN 62 OncoVEX GM CSF 62 talabostat 62 IMC A# 62 CORT # 62 Receives Orphan Drug Designation 62 Pruvel ™ 62 Valortim R 62 balsalazide tablet 62 CGEN # 62 pyrimidine nucleoside analog 62 incyclinide 62 tranilast 62 antifolates 62 Fluconazole 62 Vaprisol 62 Q#IR 62 XTEN 62 Interferon beta 62 epoetin alpha 62 selective estrogen receptor modulator 62 antiarrhythmic agent 62 Triapine 62 nanomolar 62 Icatibant 62 ZYBRESTAT fosbretabulin 62 Macrolide 62 Pruvel 62 enzyme inhibitor 62 Simulect 62 initiated Phase Ib 62 denileukin diftitox 62 Ophena TM 62 Fidaxomicin 62 HCV protease 62 Marqibo TM 62 intravesical instillation 62 AGILECT R 62 seliciclib CYC# 62 Nexavar ® 62 Rasagiline 62 Radezolid 62 HuMax TAC 62 BCX# 62 XL# anticancer compounds 62 Nitazoxanide 62 novel topoisomerase 62 Locked Nucleic Acid LNA 62 histone acetyltransferase 62 EVIZON ™ 62 Th2 cytokines 62 CYP #C# 62 TRIOLEX ™ 62 Monoclonal antibody 62 sitaxsentan 62 Phase #/#a 62 CRLX# 62 Olmesartan 62 phase IIb study 62 prucalopride 62 either acutely decompensated 62 Microplasmin 62 DiLA2 62 ribavirin USP 62 serine protease inhibitor 62 ZK EPO 62 anticancer agent 62 R#/MEM # 62 diarrhea predominant irritable 62 Ranolazine 62 proprietary polysaccharide 62 Posaconazole 62 mimetics 62 reslizumab 62 investigational hepatitis C 62 molecular imaging radiopharmaceutical 62 prodrug 62 LY# [002] 62 rilonacept 62 LibiGel ® 62 initiate Phase IIa 62 potently inhibit 62 Talabostat 62 Investigational Oral 62 Present Preclinical Data 62 dexpramipexole 62 Files IND 62 antiinflammatory 62 immuno modulatory 62 Eg5 62 dipeptidyl peptidase IV 62 GAMMAGARD 62 bardoxolone methyl 62 Allegra fexofenadine 62 zileuton 62 PKC# 62 Maxy G# 62 antitumor effects 62 azilsartan medoxomil 62 clonidine hydrochloride 62 Teriparatide 62 6R BH4 62 Ganciclovir 62 Phase Ib clinical trials 62 Pivotal Study 62 CorVue ™ 62 SAR# [002] 62 Ziprasidone 62 Telintra 62 clotrimazole 62 RiVax 62 dasatinib Sprycel ® 62 immune modulator 62 chemopreventive agent 62 Phase 2b Trial 62 APTIVUS 62 luliconazole 62 dexamethasone Decadron 62 tumor xenograft models 62 treat chronic sinusitis 62 CR# vcMMAE 62 Azedra 62 BiTE 62 Solazed 61 fluticasone furoate 61 radiolabeled 61 NeuroSTAT ® 61 interleukin IL -# 61 NV1FGF 61 angiotensin receptor blocker ARB 61 NGX# 61 sufentanil 61 Xelox 61 PI3K/Akt pathway inhibitor 61 metastatic malignant 61 Mg Uk 61 potentially hepatotoxic 61 PI3 kinase inhibitors 61 TKB# 61 SGLT2 inhibitor 61 glycoprotein GP IIb IIIa 61 IMA# 61 HuMax CD4 61 MAb 61 tasimelteon 61 CaPre TM 61 TransVax TM 61 5 HT2A inverse 61 ganaxolone 61 Cyclosporine 61 efficacy tolerability 61 liposome encapsulated 61 echinocandin 61 paclitaxel poliglumex 61 Pegasys ® 61 Tigecycline